Early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national data

Colin R Simpson, Chris Robertson, Eleftheria Vasileiou, Jim McMenamin, Rory Gunson, Lewis D Ritchie, Mark Woolhouse, Lynn Morrice, Dave Kelly, Helen R. Stagg, Diogo Marques, Josie Murray, Aziz Sheikh

Research output: Contribution to journalArticlepeer-review

Abstract

Following the emergence of the novel coronavirus SARS-CoV-2 in December 2019 and the ensuing COVID-19 pandemic, population-level surveillance and rapid assessment of the effectiveness of existing or new therapeutic or preventive interventions are required to ensure that interventions are targeted to those at highest risk of serious illness or death from COVID-19. We aim to re-purpose and expand an existing pandemic reporting platform to determine the attack rate of SARS-CoV-2, the uptake and effectiveness of any new pandemic vaccine (once available), and any protective effect conferred by existing or new antimicrobial drugs and other therapies.
Original languageEnglish
JournalBMJ Open
DOIs
Publication statusPublished - 21 Jun 2020

Fingerprint

Dive into the research topics of 'Early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national data'. Together they form a unique fingerprint.

Cite this